研究者
J-GLOBAL ID:202401017657798423   更新日: 2024年11月20日

河邉 顕

カワベ ケン | Kawabe Ken
所属機関・部署:
職名: 医長
論文 (77件):
  • Takao Ohtsuka, Hiroyuki Maguchi, Shoji Tokunaga, Susumu Hijioka, Yukiko Takayama, Shinsuke Koshita, Keiji Hanada, Kentaro Sudo, Hiroyuki Uehara, Satoshi Tanno, et al. Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2024. 24. 7. 1141-1151
  • Masatoshi Murakami, Nao Fujimori, Kohei Nakata, Masafumi Nakamura, Shinichi Hashimoto, Hiroshi Kurahara, Kazuyoshi Nishihara, Toshiya Abe, Shunpei Hashigo, Naotaka Kugiyama, et al. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2. Journal of Gastroenterology. 2023
  • Akihisa Ohno, Nao Fujimori, Toyoma Kaku, Masayuki Hijioka, Ken Kawabe, Naohiko Harada, Makoto Nakamuta, Takamasa Oono, Yoshihiro Ogawa. The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center. Clinical Endoscopy. 2022
  • Satoshi Kobayashi, Motoko Suzuki, Makoto Ueno, Yuta Maruki, Naohiro Okano, Akiko Todaka, Masato Ozaka, Kunihiro Tsuji, Kazuhiko Shioji, Keitaro Doi, et al. Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer. The oncologist. 2022. 27. 10. e774-e782
  • Yu Takamatsu, Nao Fujimori, Tsukasa Miyagahara, Yuta Suehiro, Toyoma Kaku, Ken Kawabe, Akihisa Ohno, Kazuhide Matsumoto, Masatoshi Murakami, Katsuhito Teramatsu, et al. The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction. Scientific reports. 2022. 12. 1. 9746-9746
もっと見る
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る